Evidence map›Paper›PMID 38329236›Full record

ArticleJournal of the American Chemical Society2024

Regiodivergent Radical Termination for Intermolecular Biocatalytic C-C Bond Formation.

Mark R Petchey, Yuxuan Ye, Victor Spelling, James D Finnigan, Samantha Gittings, Magnus J Johansson, Martin A Hayes, Todd K Hyster

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Next-Generation Manufacturing: The Evolving Role of Biocatalysis in AstraZeneca.Chembiochem : a European journal of chemical biology · 2026
    Review
  2. Designing and Engineering Enzymes for New-to-Nature Photobiocatalysis.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Mark R PetcheyCompound Synthesis and Management, Discovery Sciences, BioPharma R&D, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden.
Yuxuan YeDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca 14850, New York, United States.ORCID 0000-0003-3516-5270
Victor SpellingEarly Chemical Development, Pharmaceutical Sciences, BioPharma R&D, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden.ORCID 0000-0001-5976-8047
James D FinniganProzomix Ltd., Building 4, West End Industrial Estate, Haltwhistle NE49 9HA, U.K.
Samantha GittingsProzomix Ltd., Building 4, West End Industrial Estate, Haltwhistle NE49 9HA, U.K.
Magnus J JohanssonMedicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharma R&D, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden.ORCID 0000-0002-0904-2835
Martin A HayesCompound Synthesis and Management, Discovery Sciences, BioPharma R&D, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden.ORCID 0000-0002-2640-8464
Todd K HysterDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca 14850, New York, United States.ORCID 0000-0003-3560-355X
AstraZeneca (Sweden) · SECornell University · USProzomix (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radical hydrofunctionalizations of electronically unbiased dienes are challenging to render regioselective, because the products are nearly identical in energy. Here, we report two engineered FMN-dependent "ene"-reductases (EREDs) that catalyze regiodivergent hydroalkylations of cyclic and linear dienes. While previous studies focused exclusively on the stereoselectivity of alkene hydroalkylation, this work highlights that EREDs can control the regioselectivity of hydrogen atom transfer, providing a method for selectively preparing constitutional isomers that would be challenging to prepare using traditional synthetic methods. Engineering the ERED from

Indexed as

OxidoreductasesPolyenesBiocatalysisCatalysisIsomerismKetonesKetonesOxidoreductasesPolyenes

Identifiers

PMID38329236
PMCPMC10885151
OpenAlexW4391645220

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.